Key facts
| Recalling firm | ResMed Ltd. |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory support for patients weighing more than 11lb (5kg) who require mechanical ventilation. |
| Classification | Class I |
| Recall number | Z-2735-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Due to a Supercapacitor electrolyte leakage on Printed Circuit Board Assembly (PCBA) may damage the charger chip, causing fail-safe state and interruption of ventilation therapy. |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory support for patients weighing more than 11lb (5kg) who require mechanical ventilation. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from ResMed Ltd.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from ResMed Ltd. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to ResMed Ltd. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class I, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
ResMed Ltd.’s FDA history
Argus HQ has recorded 1 total FDA action tied to ResMed Ltd.: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- Is Resmed Astral 100/150 Resmed Astral 100/50 is a ventilato recalled?
- Yes. FDA lists a Class I recall by ResMed Ltd. for Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory support for patients weighing more than 11lb (5kg) who require mechanical ventilation., reported 20260805, with status "Ongoing." FDA recall number: Z-2735-2026.
- What is the recall class for ResMed Ltd.'s recall?
- FDA classified this recall as Class I. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death.
- Why was Resmed Astral 100/150 Resmed Astral 100/50 is a ventilato recalled?
- FDA's recall record states the reason as: Due to a Supercapacitor electrolyte leakage on Printed Circuit Board Assembly (PCBA) may damage the charger chip, causing fail-safe state and interruption of ventilation therapy.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for ResMed Ltd.Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Class I Recall: Resmed Astral 100/150 Resmed Astral 100/50 is a… by ResMed Ltd. — Recall Details. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/resmed-z-2735-2026-2026-08-05
"FDA Class I Recall: Resmed Astral 100/150 Resmed Astral 100/50 is a… by ResMed Ltd. — Recall Details." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/resmed-z-2735-2026-2026-08-05.
Argus HQ Research. "FDA Class I Recall: Resmed Astral 100/150 Resmed Astral 100/50 is a… by ResMed Ltd. — Recall Details." Digital Empire Holdings LLC. Accessed August 13, 2026. https://argushq.ai/recall/resmed-z-2735-2026-2026-08-05.
@misc{argushq_argushq_ai_recall_resmed_z_2735_2026_2026_08_05_2026,
title = {FDA Class I Recall: Resmed Astral 100/150 Resmed Astral 100/50 is a… by ResMed Ltd. — Recall Details},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/resmed-z-2735-2026-2026-08-05},
note = {Accessed: August 13, 2026}
}Source: FDA.gov — Recalls ↗

